News

After a final follow-up visit at Saint Luke's North Hospital, 84-year-old Carl Linck and his grandson are entering the holiday season with an extra sense of gratitude.

It was a warm, late summer day in Kansas City when Carl Linck, 84, was cruising down Interstate 29 with his 15-year-old grandson riding shotgun.

To combat rising maternal mortality, researchers at Saint Luke's Mid America Heart Institute and UMKC are leading a first of its kind study to create better care for moms with heart conditions during pregnancy.

This week we're talking with Dr. Sanjaya Gupta, cardiologist at Saint Luke’s Mid America Heart Institute, about the latest treatment options for this underdiagnosed heart condition.

Dr. Sanjaya Gupta spoke to KSHB about pulsed field ablation, as well as the second Saint Luke's patient to undergo this innovative new procedure to treat AFib.

The four-year observational study will research U.S. pregnant people with cardiovascular disease to better understand and combat maternal mortality and morbidity.

A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.

Nearly 7 million people in the U.S. are living with Alzheimer’s disease. That number is expected to double by the year 2060.

MedCity News talked to Dr. Sanjaya Gupta, cardiologist at Saint Luke's Mid America Heart Institue, about how the new virtual program to help patients with atrial fibrillation came to be.

The new, co-developed a-fib program delivers holistic care that magnifies specialty providers’ ability to see more patients and improve their quality of life.